According to reports from Hai Phong authorities, between 2023 and 2025, inter-disciplinary inspection teams conducted periodic reviews of food safety... Read more
Category: Uncategorized
AbbVie to acquire Arizona manufacturing site to bolster drug delivery capabilities
Biopharmaceutical giant AbbVie has announced a definitive agreement to acquire a device manufacturing facility in Tempe, Arizona, along with associated... Read more
AstraZeneca announces appointment of new Head of Investor Relations
On January 8, 2026, the multinational biopharmaceutical giant AstraZeneca officially announced the appointment of a new Head of Investor Relations.... Read more
EU approves first-ever therapy to delay progression of Stage 3 Type 1 Diabetes
On January 12, 2026, the European Commission officially approved Sanofi’s Teizeild (teplizumab). This marks the first disease-modifying therapy authorized in... Read more
Nearly $1B in new venture capital floods biotech in the US and EU
January 2026 has marked a vibrant start for the biomedical venture capital market with the launch of three new funds,... Read more
Billion-Dollar Deal: Merck in talks to acquire oncology firm Revolution Medicines
The global pharmaceutical market is abuzz with reports that Merck & Co. (MSD) is in active negotiations to acquire Revolution... Read more
Alveus Therapeutics enters the obesity market with $160M Series A funding
Alveus Therapeutics has made its debut following a successful $160 million Series A financing round. Led by prominent healthcare investors... Read more
Novartis expands radiopharmaceutical network with new facility in Florida
Swiss drugmaker Novartis has unveiled plans to construct a new radioligand therapy (RLT) manufacturing plant in Winter Park, Florida. This... Read more
J&J strikes drug pricing deal with US Government and reveals expansion plans
Johnson & Johnson (J&J) has officially joined the ranks of biopharma giants striking "Most-Favored-Nation" (MFN) drug pricing agreements with the... Read more









